首页 > 最新文献

International Journal of Health Planning and Management最新文献

英文 中文
Global Health Initiatives and Universal Health Coverage in Pakistan-Aligned for the Future? 全球卫生倡议和全民健康覆盖在巴基斯坦的未来?
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-11-19 DOI: 10.1002/hpm.70038
Shehla Zaidi, Shifa Salman Habib, Asad Shoaib, Zakir Shah, Karl Blanchet, Rosemary Jouhad, Natasha Palmer, Valery Ridde, Sophie Witter

There is increasing global discourse on Global Health Initiatives' (GHIs) role and the need for better alignment with universal health coverage (UHC), which is particularly salient given recent rapid reductions in global aid. However, tensions within national ecosystems of GHI assistance and country alignment towards UHC are less well understood. We identify challenges and leverage points for aligning GHIs' assistance towards UHC-focused health systems in Pakistan, drawing from the perspective of country stakeholders. A political economy approach was applied to unpack the context of national aid architecture, country discourse on strengths and weakness of GHI country ecosystem and stakeholders' power, positioning and interests for future reforms. Key informant interviews were conducted with constituencies of country-based stakeholders in federal and provincial health systems, supplemented by a desk review of health financing data and policy-programmatic documents.

The findings highlight a context of expanding GHI mandate, despite Pakistan's trajectory towards middle income country status, but weak alignment with national primary health care (PHC) budgeting and planning processes. Country discourse acknowledged improved disease coverage but surfaced tensions with the off-budget parallel grant model, comprising of several GHI intermediaries, headquarters-driven planning and selective system support, that was not positioned to build sustainability resulting in duplicative resourcing, questionable value for money, clouding of accountability roles and poor preparedness for transition. Competing interests between federal and provincial governments, and between disease managers and PHC planners, was perceived to further weaken country stewardship of GHI assistance. The prospect of an impending decline in aid funding was a common interest for change across all stakeholder constituencies. Stakeholders were positioned for a continuation of GHI assistance but with fundamental changes involving integration with national PHC budgeting, re-balancing power through shared accountability, and calibrated federal-provincial incentives for coordinated working, but most felt disempowered to bring about change.

We conclude that addressing power imbalances must be at the centre of paradigm shifts in country assistance by GHIs, although contextual modalities will differ across LMICs. Direct engagement with UHC stakeholders under the ambit of national PHC reforms, fewer intermediaries, on-budget incentives to sustainably grow domestic financing and PFM technical assistance for aid management emerged as key areas for efficient, sustainable alignment in Pakistan and similar LMICs. Urgent actions are required within the current context of changes in global aid to build local capability for systematically easing dependence on GHIs while protecting equitable gains in disease outcomes.

关于全球卫生倡议(GHIs)的作用以及更好地与全民健康覆盖(UHC)保持一致的必要性的全球讨论越来越多,鉴于最近全球援助迅速减少,这一点尤其突出。然而,人们对全球健康倡议援助的国家生态系统内部的紧张关系和国家对全民健康覆盖的协调了解较少。我们从国家利益攸关方的角度出发,确定挑战和杠杆点,使全球卫生保健机构的援助与巴基斯坦以全民健康覆盖为重点的卫生系统保持一致。本文运用政治经济学方法,分析了国家援助架构的背景、关于全球基础设施国家生态系统优缺点的国家话语、利益相关者的权力、未来改革的定位和利益。对联邦和省级卫生系统中以国家为基础的利益攸关方选区进行了重要的信息者访谈,并辅以对卫生筹资数据和政策规划文件的案头审查。研究结果强调了一个背景,即尽管巴基斯坦正朝着中等收入国家的方向发展,但GHI授权正在扩大,但与国家初级卫生保健(PHC)预算和规划过程的一致性较弱。国家讨论承认疾病覆盖得到改善,但与预算外平行赠款模式(包括几个全球健康倡议中介机构、总部驱动的规划和选择性系统支持)之间的紧张关系显现出来,这种模式无法建立可持续性,导致资源重复、资金价值可疑、问责作用模糊不清以及过渡准备不足。联邦政府和省政府之间以及疾病管理者和初级保健规划者之间的利益竞争被认为进一步削弱了国家对全球健康倡议援助的管理。援助资金即将减少的前景是所有利益攸关方变革的共同利益所在。利益相关者的定位是继续提供全球健康倡议援助,但要进行根本性的改革,包括与国家初级卫生保健预算相结合,通过共同问责重新平衡权力,以及校准联邦-省协调工作的激励措施,但大多数人感到无力带来变革。我们的结论是,解决权力不平衡问题必须成为全球高收入国家援助模式转变的核心,尽管不同中低收入国家的背景模式有所不同。在国家初级卫生保健改革的范围内,与全民健康覆盖利益攸关方直接接触,减少中介机构,以预算激励措施可持续地增加国内融资,以及为援助管理提供PFM技术援助,已成为巴基斯坦和类似中低收入国家有效、可持续协调的关键领域。在当前全球援助变化的背景下,需要采取紧急行动,建立地方能力,系统地减轻对全球免疫系统的依赖,同时保护疾病结局的公平收益。
{"title":"Global Health Initiatives and Universal Health Coverage in Pakistan-Aligned for the Future?","authors":"Shehla Zaidi,&nbsp;Shifa Salman Habib,&nbsp;Asad Shoaib,&nbsp;Zakir Shah,&nbsp;Karl Blanchet,&nbsp;Rosemary Jouhad,&nbsp;Natasha Palmer,&nbsp;Valery Ridde,&nbsp;Sophie Witter","doi":"10.1002/hpm.70038","DOIUrl":"10.1002/hpm.70038","url":null,"abstract":"<p>There is increasing global discourse on Global Health Initiatives' (GHIs) role and the need for better alignment with universal health coverage (UHC), which is particularly salient given recent rapid reductions in global aid. However, tensions within national ecosystems of GHI assistance and country alignment towards UHC are less well understood. We identify challenges and leverage points for aligning GHIs' assistance towards UHC-focused health systems in Pakistan, drawing from the perspective of country stakeholders. A political economy approach was applied to unpack the context of national aid architecture, country discourse on strengths and weakness of GHI country ecosystem and stakeholders' power, positioning and interests for future reforms. Key informant interviews were conducted with constituencies of country-based stakeholders in federal and provincial health systems, supplemented by a desk review of health financing data and policy-programmatic documents.</p><p>The findings highlight a context of expanding GHI mandate, despite Pakistan's trajectory towards middle income country status, but weak alignment with national primary health care (PHC) budgeting and planning processes. Country discourse acknowledged improved disease coverage but surfaced tensions with the off-budget parallel grant model, comprising of several GHI intermediaries, headquarters-driven planning and selective system support, that was not positioned to build sustainability resulting in duplicative resourcing, questionable value for money, clouding of accountability roles and poor preparedness for transition. Competing interests between federal and provincial governments, and between disease managers and PHC planners, was perceived to further weaken country stewardship of GHI assistance. The prospect of an impending decline in aid funding was a common interest for change across all stakeholder constituencies. Stakeholders were positioned for a continuation of GHI assistance but with fundamental changes involving integration with national PHC budgeting, re-balancing power through shared accountability, and calibrated federal-provincial incentives for coordinated working, but most felt disempowered to bring about change.</p><p>We conclude that addressing power imbalances must be at the centre of paradigm shifts in country assistance by GHIs, although contextual modalities will differ across LMICs. Direct engagement with UHC stakeholders under the ambit of national PHC reforms, fewer intermediaries, on-budget incentives to sustainably grow domestic financing and PFM technical assistance for aid management emerged as key areas for efficient, sustainable alignment in Pakistan and similar LMICs. Urgent actions are required within the current context of changes in global aid to build local capability for systematically easing dependence on GHIs while protecting equitable gains in disease outcomes.</p>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"41 1","pages":"156-170"},"PeriodicalIF":1.8,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12794120/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145557743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intermediaries and Development of Biopharmaceuticals: Evidence From the Innovation Policy in a Developing Country 中介机构与生物制药的发展:来自发展中国家创新政策的证据。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-11-04 DOI: 10.1002/hpm.70034
Atiyeh Safardoust, Fereidoun Mahboudi, Soode Mirmohammadi, Mohsen Pourqasem

Motivation

The biopharmaceutical industry in Iran has made significant progress in recent years, supported by multiple innovation policies aimed at its development. Nevertheless, challenges such as limited resources, skill and managerial gaps, weak networking, and restricted access to funding and incentives have hindered sustainable innovation.

Purpose

This study aims to examine the role of intermediaries in supporting biopharmaceutical companies and to analyze how innovation policies influence technological capabilities, networking, human capital development, and access to funding and incentives in Iran.

Approach and Methods

A qualitative approach was employed, using purposive sampling to select 19 participants from the governmental, academic, and industrial sectors. Data were collected through semi-structured interviews and analyzed using Braun and Clarke's six-step thematic analysis (2006). Data credibility and validity were ensured through member checking, triangulation, and independent coding by two researchers.

Findings

The findings indicate that innovation policies have advanced across four main dimensions—exploitation of results and production, networking and facilitation, human capital, and funding and incentives—but each dimension faces specific challenges. Intermediaries, including accelerators, technology centers, industry associations, and specialized investment funds, play a key role in addressing these challenges by providing practical training, financial and technical support, facilitating cross-sector collaborations, and establishing professional networks, thereby fostering sustainable development and innovation in the biopharmaceutical sector.

Policy Implications

Strengthening intermediaries and implementing targeted policies based on companies' real needs can enhance the effectiveness of innovation policies, reduce import dependence, and improve the global competitiveness of Iran's biopharmaceutical industry.

动机:近年来,伊朗的生物制药行业在多项创新政策的支持下取得了重大进展。然而,资源有限、技能和管理差距、网络薄弱以及获得资金和激励的渠道有限等挑战阻碍了可持续创新。目的:本研究旨在考察中介机构在支持生物制药公司方面的作用,并分析创新政策如何影响伊朗的技术能力、网络、人力资本开发以及获得资金和激励措施。方法和方法:采用定性方法,从政府、学术和工业部门中选择19名参与者。通过半结构化访谈收集数据,并使用Braun和Clarke的六步主题分析(2006)进行分析。通过成员检验、三角测量和两位研究者独立编码,保证了数据的可信度和有效性。研究结果:研究结果表明,创新政策在四个主要方面取得了进展——成果和生产的利用、网络和促进、人力资本、资金和激励——但每个方面都面临着具体的挑战。中介机构,包括加速器、技术中心、行业协会和专业投资基金,通过提供实践培训、资金和技术支持、促进跨部门合作和建立专业网络,在应对这些挑战方面发挥关键作用,从而促进生物制药行业的可持续发展和创新。政策启示:加强中介机构,根据企业的实际需求实施有针对性的政策,可以提高创新政策的有效性,减少进口依赖,提高伊朗生物制药产业的全球竞争力。
{"title":"Intermediaries and Development of Biopharmaceuticals: Evidence From the Innovation Policy in a Developing Country","authors":"Atiyeh Safardoust,&nbsp;Fereidoun Mahboudi,&nbsp;Soode Mirmohammadi,&nbsp;Mohsen Pourqasem","doi":"10.1002/hpm.70034","DOIUrl":"10.1002/hpm.70034","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Motivation</h3>\u0000 \u0000 <p>The biopharmaceutical industry in Iran has made significant progress in recent years, supported by multiple innovation policies aimed at its development. Nevertheless, challenges such as limited resources, skill and managerial gaps, weak networking, and restricted access to funding and incentives have hindered sustainable innovation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>This study aims to examine the role of intermediaries in supporting biopharmaceutical companies and to analyze how innovation policies influence technological capabilities, networking, human capital development, and access to funding and incentives in Iran.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Approach and Methods</h3>\u0000 \u0000 <p>A qualitative approach was employed, using purposive sampling to select 19 participants from the governmental, academic, and industrial sectors. Data were collected through semi-structured interviews and analyzed using Braun and Clarke's six-step thematic analysis (2006). Data credibility and validity were ensured through member checking, triangulation, and independent coding by two researchers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Findings</h3>\u0000 \u0000 <p>The findings indicate that innovation policies have advanced across four main dimensions—exploitation of results and production, networking and facilitation, human capital, and funding and incentives—but each dimension faces specific challenges. Intermediaries, including accelerators, technology centers, industry associations, and specialized investment funds, play a key role in addressing these challenges by providing practical training, financial and technical support, facilitating cross-sector collaborations, and establishing professional networks, thereby fostering sustainable development and innovation in the biopharmaceutical sector.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Policy Implications</h3>\u0000 \u0000 <p>Strengthening intermediaries and implementing targeted policies based on companies' real needs can enhance the effectiveness of innovation policies, reduce import dependence, and improve the global competitiveness of Iran's biopharmaceutical industry.</p>\u0000 </section>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"41 1","pages":"132-155"},"PeriodicalIF":1.8,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145446273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of Surgery Duration Based on Machine Learning Algorithms and Its Practical Application in a General Hospital in China 基于机器学习算法的手术时间预测及其在某综合医院的实际应用
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-11-03 DOI: 10.1002/hpm.70032
Haoran Wu, Yueyuan Cai, Yuefang Chen, Li Xia, Lin Yao

This study aims to optimise operating room scheduling and improve hospital operational efficiency by predicting surgery durations using machine learning algorithms. Traditional methods often face challenges in accuracy, while machine learning models offer superior predictive performance. Using real-world operating room data from a large general hospital in China, the study compares various machine learning algorithms and selects the XGBoost model as the most effective predictive framework. Three types of models were developed: an all-inclusive model, a department-specific model, and a doctor-specific model. The department-specific model demonstrated the highest accuracy, outperforming the others. The results were applied to the hospital's surgical centre scheduling process, significantly enhancing operating room resource utilisation. The study highlights the importance of data preprocessing and feature selection in improving prediction accuracy. Overall, machine learning-based surgery duration prediction can effectively address challenges in surgical scheduling and provide data-driven support for hospital operational management.

本研究旨在通过使用机器学习算法预测手术持续时间,优化手术室调度,提高医院运营效率。传统方法在准确性方面经常面临挑战,而机器学习模型提供了优越的预测性能。该研究使用了中国一家大型综合医院的真实手术室数据,比较了各种机器学习算法,并选择了XGBoost模型作为最有效的预测框架。开发了三种类型的模型:全包模型、特定科室模型和特定医生模型。特定部门模型显示出最高的准确性,优于其他模型。结果应用于医院的手术中心调度过程,显著提高了手术室资源的利用率。研究强调了数据预处理和特征选择对提高预测精度的重要性。总的来说,基于机器学习的手术持续时间预测可以有效地解决手术调度中的挑战,并为医院运营管理提供数据驱动的支持。
{"title":"Prediction of Surgery Duration Based on Machine Learning Algorithms and Its Practical Application in a General Hospital in China","authors":"Haoran Wu,&nbsp;Yueyuan Cai,&nbsp;Yuefang Chen,&nbsp;Li Xia,&nbsp;Lin Yao","doi":"10.1002/hpm.70032","DOIUrl":"10.1002/hpm.70032","url":null,"abstract":"<div>\u0000 \u0000 <p>This study aims to optimise operating room scheduling and improve hospital operational efficiency by predicting surgery durations using machine learning algorithms. Traditional methods often face challenges in accuracy, while machine learning models offer superior predictive performance. Using real-world operating room data from a large general hospital in China, the study compares various machine learning algorithms and selects the XGBoost model as the most effective predictive framework. Three types of models were developed: an all-inclusive model, a department-specific model, and a doctor-specific model. The department-specific model demonstrated the highest accuracy, outperforming the others. The results were applied to the hospital's surgical centre scheduling process, significantly enhancing operating room resource utilisation. The study highlights the importance of data preprocessing and feature selection in improving prediction accuracy. Overall, machine learning-based surgery duration prediction can effectively address challenges in surgical scheduling and provide data-driven support for hospital operational management.</p>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"41 1","pages":"121-131"},"PeriodicalIF":1.8,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sustainable Health Care Public-Private Partnerships in Emerging Economies 新兴经济体的可持续卫生保健公私伙伴关系。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-10-30 DOI: 10.1002/hpm.70036
Roberto Moro-Visconti

This study examines the sustainability performance of health care Public-Private Partnerships (PPPs) in emerging economies across economic, social, and environmental dimensions. Using panel data from 148 projects in 22 countries (2005–2022) and a multilayer network framework, it compares PPPs with traditional procurement. Results show that PPPs improve financing, access, and patient satisfaction, with moderate environmental gains. Governance quality and macroeconomic stability enhance these effects, while interdependencies reveal how advances in one area reinforce those in others. The analysis links PPP outcomes to Sustainable Development Goals (SDGs 3, 9, 10, 12, 13, and 16) and confirms robustness through alternative indices and models. This is the first integrated evaluation of health care PPPs in emerging economies, offering guidance for embedding ESG standards, resilience clauses, and monitoring benchmarks.

本研究从经济、社会和环境三个方面考察了新兴经济体中医疗保健公私伙伴关系(ppp)的可持续性绩效。利用来自22个国家(2005-2022年)148个项目的面板数据和多层网络框架,将ppp与传统采购进行了比较。结果表明,公私伙伴关系改善了融资、可及性和患者满意度,并有适度的环境收益。治理质量和宏观经济稳定性增强了这些影响,而相互依赖性揭示了一个领域的进步如何加强其他领域的进步。该分析将PPP成果与可持续发展目标(可持续发展目标3、9、10、12、13和16)联系起来,并通过替代指标和模型确认了其稳健性。这是对新兴经济体医疗保健公私合作伙伴关系的首次综合评估,为嵌入ESG标准、弹性条款和监测基准提供指导。
{"title":"Sustainable Health Care Public-Private Partnerships in Emerging Economies","authors":"Roberto Moro-Visconti","doi":"10.1002/hpm.70036","DOIUrl":"10.1002/hpm.70036","url":null,"abstract":"<p>This study examines the sustainability performance of health care Public-Private Partnerships (PPPs) in emerging economies across economic, social, and environmental dimensions. Using panel data from 148 projects in 22 countries (2005–2022) and a multilayer network framework, it compares PPPs with traditional procurement. Results show that PPPs improve financing, access, and patient satisfaction, with moderate environmental gains. Governance quality and macroeconomic stability enhance these effects, while interdependencies reveal how advances in one area reinforce those in others. The analysis links PPP outcomes to Sustainable Development Goals (SDGs 3, 9, 10, 12, 13, and 16) and confirms robustness through alternative indices and models. This is the first integrated evaluation of health care PPPs in emerging economies, offering guidance for embedding ESG standards, resilience clauses, and monitoring benchmarks.</p>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"41 1","pages":"107-120"},"PeriodicalIF":1.8,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12794126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145410464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prioritising Public Health Services in Danish Municipalities: A Political Balancing Act 丹麦市政当局优先考虑公共卫生服务:一项政治平衡法案。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-10-26 DOI: 10.1002/hpm.70033
Calina Leonhardt, Christina Bjørk Petersen, Marie Broholm-Holst, Sigurd Lauridsen, Morten Hulvej Rod, Ditte Heering Holt

Prioritisation in public health is complex, as decision-makers must allocate limited resources across diverse health concerns, risk factors, and target groups. In Denmark, municipalities play a central role under the Danish Health Act §119, which mandates health promotion and preventive services. However, municipalities face challenges in balancing competing needs without clear guidance. This qualitative study explores how municipalities navigate public health prioritisation, through in-depth interviews with 21 health directors and managers from 15 municipalities, selected for demographic, socio-economic, and geographical diversity. Data were analysed using systematic text condensation (STC). The findings highlight the following six themes which are central to understanding how municipalities prioritise within health promotion and prevention: (1) Economic considerations: Prioritising short-term, patient-focused services under budget constraints, (2) Public health data: Prioritising services based on locally identified health challenges, (3) Legal frameworks: Focusing on mandated services amid ambiguous legislation, (4) Evidence and evaluation: Selecting interventions with perceived effectiveness, (5) Political context: Aligning health priorities with agendas and ideological acceptability, and (6) Demographic and geographic conditions: Adapting services to local realities. We find that municipalities adopt a pragmatic, consensus-driven approach, but prioritisation processes vary, leading to disparities in service provision. Using Kingdon's Multiple Streams Framework, we discuss how municipalities frame health issues, select policy solutions, and navigate political contexts. The study highlights the need for clearer national frameworks to promote equitable public health access.

公共卫生的优先次序是复杂的,因为决策者必须将有限的资源分配给不同的卫生问题、风险因素和目标群体。在丹麦,市政当局根据《丹麦卫生法》第119条发挥核心作用,该法规定提供健康促进和预防服务。然而,在没有明确指导的情况下,市政当局在平衡相互竞争的需求方面面临挑战。这项定性研究通过对15个城市的21名卫生主管和管理人员进行深入访谈,探讨了市政当局如何确定公共卫生的优先次序,这些人是根据人口、社会经济和地理多样性选择的。数据分析采用系统文本浓缩(STC)。调查结果强调了以下六个主题,这对于理解市政当局如何在健康促进和预防方面优先考虑问题至关重要:(1)经济考虑:在预算限制下优先考虑短期、以患者为中心的服务;(2)公共卫生数据:根据当地确定的健康挑战优先考虑服务;(3)法律框架:在模棱两可的立法中重点关注强制性服务;(4)证据和评估:(5)政治背景:使卫生优先事项与议程和意识形态可接受性保持一致;(6)人口和地理条件:使服务适应当地现实。我们发现,市政当局采用务实、共识驱动的方法,但优先顺序各不相同,导致服务提供的差异。使用Kingdon的多流框架,我们讨论了市政当局如何构建健康问题,选择政策解决方案,并在政治背景下导航。该研究强调需要更明确的国家框架来促进公平的公共卫生获取。
{"title":"Prioritising Public Health Services in Danish Municipalities: A Political Balancing Act","authors":"Calina Leonhardt,&nbsp;Christina Bjørk Petersen,&nbsp;Marie Broholm-Holst,&nbsp;Sigurd Lauridsen,&nbsp;Morten Hulvej Rod,&nbsp;Ditte Heering Holt","doi":"10.1002/hpm.70033","DOIUrl":"10.1002/hpm.70033","url":null,"abstract":"<div>\u0000 \u0000 <p>Prioritisation in public health is complex, as decision-makers must allocate limited resources across diverse health concerns, risk factors, and target groups. In Denmark, municipalities play a central role under the Danish Health Act §119, which mandates health promotion and preventive services. However, municipalities face challenges in balancing competing needs without clear guidance. This qualitative study explores how municipalities navigate public health prioritisation, through in-depth interviews with 21 health directors and managers from 15 municipalities, selected for demographic, socio-economic, and geographical diversity. Data were analysed using systematic text condensation (STC). The findings highlight the following six themes which are central to understanding how municipalities prioritise within health promotion and prevention: (1) Economic considerations: Prioritising short-term, patient-focused services under budget constraints, (2) Public health data: Prioritising services based on locally identified health challenges, (3) Legal frameworks: Focusing on mandated services amid ambiguous legislation, (4) Evidence and evaluation: Selecting interventions with perceived effectiveness, (5) Political context: Aligning health priorities with agendas and ideological acceptability, and (6) Demographic and geographic conditions: Adapting services to local realities. We find that municipalities adopt a pragmatic, consensus-driven approach, but prioritisation processes vary, leading to disparities in service provision. Using Kingdon's Multiple Streams Framework, we discuss how municipalities frame health issues, select policy solutions, and navigate political contexts. The study highlights the need for clearer national frameworks to promote equitable public health access.</p>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"41 1","pages":"94-106"},"PeriodicalIF":1.8,"publicationDate":"2025-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145373018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demographic Moderation of Healthcare Expenditure Associated With Home-Based Deaths: A Longitudinal Ecological Study in Japanese Municipalities, 2015–2022 与家庭死亡相关的医疗保健支出的人口调节:2015-2022年日本城市的纵向生态研究
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-10-21 DOI: 10.1002/hpm.70031
Takemasa Ishikawa, Yoshiyuki Takashima

Introduction

Home-based end-of-life care has gained policy attention in Japan. However, its fiscal consequences remain unclear. Rising healthcare costs and rapid population ageing heighten the policy relevance of such evidence.

Objectives

To assess how the municipal home-based death rate relates to per capita medical and long-term care insurance (LTCI) spending, and whether ageing modifies these associations.

Methods

We analysed panel data from 1741 municipalities (2015–2022). Outcomes were log-transformed total and inpatient medical spending per resident and LTCI spending per certified individual. The exposure was the one-year-lagged home-based death rate, defined as home deaths divided by all deaths. Fixed-effects regressions controlled for year, ageing rate, population density (per km2 of habitable land), income-tax revenue, and health and long-term care resources. Cluster-robust standard errors addressed within-municipality serial correlation. All analyses were conducted in Python 3.11 using the linearmodels package.

Results

The mean home-based death rate was 12.3% (SD = 5.72). Each one-percentage-point increase predicted 0.001 (95% CI: 1.178 × 10^−4–0.0018) and 0.001 (95% CI: 1.900 × 10^10–0.001) log-point increases in total and inpatient spending, with no association for LTCI. Ageing moderated this relationship: at approximately 39.5% ageing, higher home-based death rates predicted lower medical costs. Greater population density (total only) and lower taxable income were also associated with higher medical spending.

Conclusion

The fiscal impact of home-based deaths is context dependent. In more aged municipalities, promoting home dying may yield medical savings, whereas younger areas may face short-term cost growth. Distinct cost dynamics between medical and LTCI systems warrant locally tailored end-of-life policies.

导言:居家临终关怀在日本已引起政策关注。然而,其财政后果仍不明朗。不断上升的医疗成本和快速的人口老龄化加剧了这些证据的政策相关性。目的:评估城市家庭死亡率与人均医疗和长期护理保险(LTCI)支出的关系,以及老龄化是否改变了这些关联。方法:我们分析了来自1741个城市(2015-2022)的面板数据。结果是对数转换后的每位居民的总住院医疗支出和每位认证个人的LTCI支出。暴露量是滞后一年的家庭死亡率,定义为家庭死亡除以所有死亡。固定效应回归控制了年份、老龄化率、人口密度(每平方公里可居住土地)、所得税收入以及健康和长期护理资源。聚类鲁棒标准误差解决了城市内序列相关性。所有分析都是在Python 3.11中使用线性模型包进行的。结果:平均家庭死亡率为12.3% (SD = 5.72)。每增加一个百分点,总住院费用和住院费用将分别增加0.001 (95% CI: 1.178 × 10^-4-0.0018)和0.001 (95% CI: 1.900 × 10^- 10-0.001)个对数点,与长期住院费用无关。老龄化缓和了这种关系:在大约39.5%的老龄化中,较高的家庭死亡率预示着较低的医疗费用。较高的人口密度(仅限总数)和较低的应税收入也与较高的医疗支出有关。结论:家庭死亡的财政影响取决于具体情况。在老龄化程度较高的城市,提倡在家死亡可能会节省医疗费用,而较年轻的地区可能会面临短期成本增长。医疗和LTCI系统之间不同的成本动态保证了当地量身定制的生命末期政策。
{"title":"Demographic Moderation of Healthcare Expenditure Associated With Home-Based Deaths: A Longitudinal Ecological Study in Japanese Municipalities, 2015–2022","authors":"Takemasa Ishikawa,&nbsp;Yoshiyuki Takashima","doi":"10.1002/hpm.70031","DOIUrl":"10.1002/hpm.70031","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Home-based end-of-life care has gained policy attention in Japan. However, its fiscal consequences remain unclear. Rising healthcare costs and rapid population ageing heighten the policy relevance of such evidence.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To assess how the municipal home-based death rate relates to per capita medical and long-term care insurance (LTCI) spending, and whether ageing modifies these associations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We analysed panel data from 1741 municipalities (2015–2022). Outcomes were log-transformed total and inpatient medical spending per resident and LTCI spending per certified individual. The exposure was the one-year-lagged home-based death rate, defined as home deaths divided by all deaths. Fixed-effects regressions controlled for year, ageing rate, population density (per km<sup>2</sup> of habitable land), income-tax revenue, and health and long-term care resources. Cluster-robust standard errors addressed within-municipality serial correlation. All analyses were conducted in Python 3.11 using the <i>linearmodels</i> package.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The mean home-based death rate was 12.3% (SD = 5.72). Each one-percentage-point increase predicted 0.001 (95% CI: 1.178 × 10^−4–0.0018) and 0.001 (95% CI: 1.900 × 10^10–0.001) log-point increases in total and inpatient spending, with no association for LTCI. Ageing moderated this relationship: at approximately 39.5% ageing, higher home-based death rates predicted lower medical costs. Greater population density (total only) and lower taxable income were also associated with higher medical spending.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The fiscal impact of home-based deaths is context dependent. In more aged municipalities, promoting home dying may yield medical savings, whereas younger areas may face short-term cost growth. Distinct cost dynamics between medical and LTCI systems warrant locally tailored end-of-life policies.</p>\u0000 </section>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"41 1","pages":"82-93"},"PeriodicalIF":1.8,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers and Enablers to Allied Health Professionals Working in Advanced and Extended Scope of Practice in Healthcare Settings: A Scoping Review 在高级和扩展的范围内工作的联合卫生专业人员的障碍和促进因素在医疗保健设置:范围审查。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-10-15 DOI: 10.1002/hpm.70030
Luc D. Govedarica, Ella Hobbs, Jordan South, Tori Lowe, Saravana Kumar

Background

As the demand for health services continues to surge, maximising the existing health workforce to its full scope of practice is critical. It is in this context, allied health professionals (AHPs) have a long history of working in advanced and extended scope of practice (AESP). Despite proven effectiveness, implementation of these roles continues to face challenges. A scoping review of the literature was conducted to map the barriers and enablers to allied health professionals working in AESP roles.

Methods

An apriori protocol was developed and the methodology was informed by the ‘Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews’. Quantitative and qualitative studies were included. The search was conducted using OVID (MEDLINE, EmCare, EmBase, PsycINFO) CINAHL, Cochrane Library, Scopus and Google Scholar in April 2025. Two reviewers independently screened records, following which data extraction was undertaken. Normalisation Process Theory was used as an overarching framework for descriptive synthesis.

Results

Nineteen studies of varying designs and methodologies were included. Barriers and enablers to AESP implementation were mapped across three overarching themes: Personal, Organisational, and System-level factors, reflecting the complexity of embedding such roles into routine practice. The identified enablers and barriers were multifactorial and interconnected, highlighting the critical need for strong organisational support and leadership, long-term workforce planning, and context-specific strategies to ensure the sustainability of AESP roles.

Conclusion

As many barriers and enablers appeared to be two sides of the same coin, this duality underscores the need for context-specific, stakeholder-informed, and multifaceted implementation strategies.

背景:由于对卫生服务的需求持续激增,使现有卫生人力最大限度地发挥其全部作用至关重要。正是在这种背景下,联合卫生专业人员(ahp)在高级和扩展的实践范围(AESP)中有着悠久的工作历史。尽管证明了这些角色的有效性,但实施这些角色仍然面临挑战。对文献进行了范围审查,以绘制在AESP角色中工作的专职卫生专业人员的障碍和促进因素。方法:制定了一个先验方案,方法由“系统评价的首选报告项目和范围评价的元分析扩展”通知。包括定量和定性研究。检索于2025年4月使用OVID (MEDLINE, EmCare, EmBase, PsycINFO)、CINAHL、Cochrane Library、Scopus和谷歌Scholar进行。两名审稿人独立筛选记录,然后进行数据提取。规范化过程理论被用作描述性综合的总体框架。结果:纳入了19项不同设计和方法的研究。AESP实施的障碍和推动因素跨越三个主要主题:个人、组织和系统级因素,反映了将这些角色嵌入到日常实践中的复杂性。确定的推动因素和障碍是多因素和相互关联的,突出了对强有力的组织支持和领导、长期劳动力规划和特定环境战略的迫切需求,以确保AESP角色的可持续性。结论:由于许多障碍和推动因素似乎是同一枚硬币的两面,这种两重性强调了对特定于环境、利益相关者知情和多方面实施战略的需求。
{"title":"Barriers and Enablers to Allied Health Professionals Working in Advanced and Extended Scope of Practice in Healthcare Settings: A Scoping Review","authors":"Luc D. Govedarica,&nbsp;Ella Hobbs,&nbsp;Jordan South,&nbsp;Tori Lowe,&nbsp;Saravana Kumar","doi":"10.1002/hpm.70030","DOIUrl":"10.1002/hpm.70030","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>As the demand for health services continues to surge, maximising the existing health workforce to its full scope of practice is critical. It is in this context, allied health professionals (AHPs) have a long history of working in advanced and extended scope of practice (AESP). Despite proven effectiveness, implementation of these roles continues to face challenges. A scoping review of the literature was conducted to map the barriers and enablers to allied health professionals working in AESP roles.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An apriori protocol was developed and the methodology was informed by the ‘Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews’. Quantitative and qualitative studies were included. The search was conducted using OVID (MEDLINE, EmCare, EmBase, PsycINFO) CINAHL, Cochrane Library, Scopus and Google Scholar in April 2025. Two reviewers independently screened records, following which data extraction was undertaken. Normalisation Process Theory was used as an overarching framework for descriptive synthesis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Nineteen studies of varying designs and methodologies were included. Barriers and enablers to AESP implementation were mapped across three overarching themes: Personal, Organisational, and System-level factors, reflecting the complexity of embedding such roles into routine practice. The identified enablers and barriers were multifactorial and interconnected, highlighting the critical need for strong organisational support and leadership, long-term workforce planning, and context-specific strategies to ensure the sustainability of AESP roles.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>As many barriers and enablers appeared to be two sides of the same coin, this duality underscores the need for context-specific, stakeholder-informed, and multifaceted implementation strategies.</p>\u0000 </section>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"41 1","pages":"234-252"},"PeriodicalIF":1.8,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sovereign Wealth Fund Typologies and Healthcare Investment: An Exploratory Study of Six Cases Through an Agency Theory Lens 主权财富基金类型与医疗投资:代理理论视角下六个案例的探索性研究。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-10-14 DOI: 10.1002/hpm.70029
Rita McGrath

Sovereign Wealth Funds (SWFs), managing over USD 13 trillion globally, are increasingly active in healthcare. Yet research often treats them as uniform, overlooking how mandates may shape strategies. This study explores whether typologies, savings, stabilisation, and development suggest distinct approaches to healthcare investment. Using Agency Theory and a multiple-case design, six funds were analysed across diverse contexts: Mubadala (UAE), Temasek (Singapore in India), GIC (Singapore in Malaysia), ADQ (UAE in Egypt), the New Zealand Superannuation Fund (NZSF), and the Nigeria Sovereign Investment Authority (NSIA). Findings indicate preliminary patterns. Stabilisation funds pursue conservative, infrastructure-heavy strategies to preserve liquidity. Savings funds deploy patient capital adaptively, emphasising innovation in strong systems and scalable delivery in moderate ones. Development funds align with state priorities, focussing on politically salient infrastructure even in moderate governance settings. Together, these patterns offer exploratory propositions that provide a foundation for further testing. The study contributes by extending Agency Theory to show how agency challenges differ by fund type, and by offering policymakers and healthcare leaders a framework to anticipate SWF behaviour and structure partnerships. While limited to six cases, with single-case representation for stabilisation and development funds, the framework provides a basis for future testing and for examining health outcomes such as access, innovation, and resilience. Recognising SWF heterogeneity is essential to aligning sovereign capital with sustainable healthcare.

主权财富基金(SWFs)在全球管理着超过13万亿美元的资金,在医疗保健领域日益活跃。然而,研究往往将它们视为统一的,忽视了授权如何影响战略。本研究探讨类型学、储蓄、稳定和发展是否建议不同的医疗保健投资方法。运用代理理论和多案例设计,在不同背景下分析了6只基金:穆巴达拉(阿联酋)、淡马锡(印度新加坡)、GIC(马来西亚新加坡)、ADQ(埃及阿联酋)、新西兰退休基金(NZSF)和尼日利亚主权投资局(NSIA)。调查结果表明了初步模式。稳定基金采取保守的、以基础设施为主的策略来保持流动性。储蓄基金对耐心资本的配置具有适应性,强调强大系统的创新和中等系统的可扩展交付。发展基金与国家优先事项保持一致,即使在治理温和的环境中,也将重点放在政治上突出的基础设施上。总之,这些模式提供了探索性命题,为进一步的测试奠定了基础。这项研究的贡献在于扩展了代理理论,展示了不同基金类型的代理挑战是如何不同的,并为政策制定者和医疗保健领导者提供了一个框架,以预测主权财富基金的行为和构建合作关系。虽然该框架仅限于6个案例,稳定和发展基金的案例代表单一,但它为未来的测试和审查诸如获取、创新和复原力等卫生成果提供了基础。认识到主权财富基金的异质性对于使主权资本与可持续医疗保健保持一致至关重要。
{"title":"Sovereign Wealth Fund Typologies and Healthcare Investment: An Exploratory Study of Six Cases Through an Agency Theory Lens","authors":"Rita McGrath","doi":"10.1002/hpm.70029","DOIUrl":"10.1002/hpm.70029","url":null,"abstract":"<div>\u0000 \u0000 <p>Sovereign Wealth Funds (SWFs), managing over USD 13 trillion globally, are increasingly active in healthcare. Yet research often treats them as uniform, overlooking how mandates may shape strategies. This study explores whether typologies, savings, stabilisation, and development suggest distinct approaches to healthcare investment. Using Agency Theory and a multiple-case design, six funds were analysed across diverse contexts: Mubadala (UAE), Temasek (Singapore in India), GIC (Singapore in Malaysia), ADQ (UAE in Egypt), the New Zealand Superannuation Fund (NZSF), and the Nigeria Sovereign Investment Authority (NSIA). Findings indicate preliminary patterns. Stabilisation funds pursue conservative, infrastructure-heavy strategies to preserve liquidity. Savings funds deploy patient capital adaptively, emphasising innovation in strong systems and scalable delivery in moderate ones. Development funds align with state priorities, focussing on politically salient infrastructure even in moderate governance settings. Together, these patterns offer exploratory propositions that provide a foundation for further testing. The study contributes by extending Agency Theory to show how agency challenges differ by fund type, and by offering policymakers and healthcare leaders a framework to anticipate SWF behaviour and structure partnerships. While limited to six cases, with single-case representation for stabilisation and development funds, the framework provides a basis for future testing and for examining health outcomes such as access, innovation, and resilience. Recognising SWF heterogeneity is essential to aligning sovereign capital with sustainable healthcare.</p>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"41 1","pages":"71-81"},"PeriodicalIF":1.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
‘I Think From the Beginning, the Ambitions Were Compromised’: A Case Study of COVAX as Vaccine Equity Policy Operationalisation “我认为从一开始,雄心就受到了损害”:COVAX作为疫苗公平政策运作的案例研究。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-09-30 DOI: 10.1002/hpm.70028
Charnele Nunes, Martin Mckee, Simon Rushton, Natasha Howard

Background

COVAX was designed to support the discovery, development, and distribution of COVID-19 vaccines globally, at scale and pace. This article examines how COVAX promoted vaccine equity and what lessons can be learnt.

Methods

Informed by a scoping review of lessons learnt from GHPs, we reviewed 109 documents related to COVAX and other GHPs and conducted 23 key informant interviews with representatives from GHPs, civil society, academia, and the private sector. Data were synthesised thematically using Rushton and Williams's framework.

Results

Data showed how the global health policy context shaped COVAX, with experience with Gavi and CEPI influencing its governance structure. We highlighted weaknesses in transparency and accountability, limited engagement with civil society organisations [CSO] and LMIC stakeholders, contested policy debates (e.g., different framing) and paradigms (e.g., prioritising technical and financial over political solutions).

Conclusions

COVAX largely replicated existing GHP approaches, subsidising research and development and then paying for resulting discoveries. While recognising how this reflects global power structures, in the inevitable next global health crisis, the international health community must advocate for greater LMIC and CSO involvement in decision-making, sharing of intellectual property and technology transfer, and rebalancing of flows of innovation costs and benefits to a broader range of actors across public and private sectors.

背景:COVAX旨在支持在全球范围内以规模和速度发现、开发和分发COVID-19疫苗。本文探讨了全球获取疫苗计划如何促进疫苗公平以及可以吸取哪些教训。方法:通过对全球疫苗计划的经验教训进行范围审查,我们审查了109份与全球疫苗计划和其他全球疫苗计划相关的文件,并与全球疫苗计划、民间社会、学术界和私营部门的代表进行了23次关键信息提供者访谈。使用Rushton和Williams的框架对数据进行主题合成。结果:数据显示了全球卫生政策背景如何塑造了全球疫苗获取计划,全球疫苗和免疫联盟的经验影响了其治理结构。我们强调了在透明度和问责制方面的弱点,与民间社会组织和中低收入国家利益相关者的接触有限,有争议的政策辩论(例如,不同的框架)和范式(例如,优先考虑技术和财政而不是政治解决方案)。结论:COVAX在很大程度上复制了现有的GHP方法,为研究和开发提供补贴,然后为由此产生的发现付费。在认识到这如何反映全球权力结构的同时,在不可避免的下一次全球卫生危机中,国际卫生界必须倡导低收入和中等收入国家和公民社会组织更多地参与决策,分享知识产权和技术转让,以及重新平衡创新成本和收益流向公共和私营部门更广泛的行为体。
{"title":"‘I Think From the Beginning, the Ambitions Were Compromised’: A Case Study of COVAX as Vaccine Equity Policy Operationalisation","authors":"Charnele Nunes,&nbsp;Martin Mckee,&nbsp;Simon Rushton,&nbsp;Natasha Howard","doi":"10.1002/hpm.70028","DOIUrl":"10.1002/hpm.70028","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>COVAX was designed to support the discovery, development, and distribution of COVID-19 vaccines globally, at scale and pace. This article examines how COVAX promoted vaccine equity and what lessons can be learnt.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Informed by a scoping review of lessons learnt from GHPs, we reviewed 109 documents related to COVAX and other GHPs and conducted 23 key informant interviews with representatives from GHPs, civil society, academia, and the private sector. Data were synthesised thematically using Rushton and Williams's framework.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Data showed how the global health policy context shaped COVAX, with experience with Gavi and CEPI influencing its governance structure. We highlighted weaknesses in transparency and accountability, limited engagement with civil society organisations [CSO] and LMIC stakeholders, contested policy debates (e.g., different framing) and paradigms (e.g., prioritising technical and financial over political solutions).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>COVAX largely replicated existing GHP approaches, subsidising research and development and then paying for resulting discoveries. While recognising how this reflects global power structures, in the inevitable next global health crisis, the international health community must advocate for greater LMIC and CSO involvement in decision-making, sharing of intellectual property and technology transfer, and rebalancing of flows of innovation costs and benefits to a broader range of actors across public and private sectors.</p>\u0000 </section>\u0000 </div>","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"41 1","pages":"59-70"},"PeriodicalIF":1.8,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12794133/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145201578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linking Health Financing to Oral Health Coverage and Disease Burden in SEARO Countries: A Cross-Sectional Analysis of Country Level Data 将卫生筹资与东南亚国家口腔健康覆盖和疾病负担联系起来:国家层面数据的横断面分析。
IF 1.8 4区 医学 Q3 HEALTH POLICY & SERVICES Pub Date : 2025-09-30 DOI: 10.1002/hpm.70027
Shashidhar Acharya, Manu Raj Mathur, Santosh Kumar Tadakamadla, Angela Brand
<div> <section> <h3> Introduction</h3> <p>The Southeast Asian region of World Health Organization (SEARO) comprising 11 countries, that is Bangladesh, Bhutan, Democratic People's Republic of Korea, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand, and Timor-Leste is home to a quarter of the world's population where severe oral health disparities persist.</p> </section> <section> <h3> Aim</h3> <p>This study aims to collate the oral health financing landscape, evaluate the relationship between government health expenditure and the burden of oral diseases, assess the proportionality of oral health spending relative to its share of the overall disease burden, and examine the inclusion and funding of dental care within Universal Health Coverage (UHC) benefit packages in the SEARO region.</p> </section> <section> <h3> Materials and Methods</h3> <p>Data for this study were sourced from publicly available databases and relevant national health statistics repositories of SEARO countries. These datasets provided information on health financing indicators, oral health coverage, and oral disease burden. Descriptive statistics were used to summarize indicators across SEARO countries. Correlation analyses were done to examine the interrelationship between health financing indicators and oral health outcomes and oral health coverage.</p> </section> <section> <h3> Results</h3> <p>Increased government expenditure on health was significantly and positively correlated with insurance and oral health coverage. It was inversely correlated with out-of-pocket expenses (OOPE), private health expenditure, borrowing money to cover health expenses, and ‘All cause’ DALYs (Disability Adjusted Life Years). There was no significant correlation between government health spending and ‘Oral Disorders’ DALYs. Increased private expenditure was inversely correlated with domestic general government health expenditure as a percentage of current health expenditure and oral health coverage and positively correlated with Out-of-pocket expenses and borrowing money for covering health expenses. The allocation of government spending did not correspond proportionately to the burden of oral diseases.</p> </section> <section> <h3> Discussion and Conclusion</h3> <p>The lack of correlation between government health funding and the oral disease burden and the disproportionately low government expenditure on oral health relative to the burden of oral diseases when compared to their sha
世界卫生组织东南亚区域由11个国家组成,即孟加拉国、不丹、朝鲜民主主义人民共和国、印度、印度尼西亚、马尔代夫、缅甸、尼泊尔、斯里兰卡、泰国和东帝汶,占世界人口的四分之一,这些国家的口腔健康差距仍然严重。目的:本研究旨在整理口腔卫生融资格局,评估政府卫生支出与口腔疾病负担之间的关系,评估口腔卫生支出相对于总体疾病负担的比例,并检查全民健康覆盖(UHC)福利计划中牙科保健的纳入和资助情况。材料和方法:本研究的数据来自可公开获取的数据库和东南亚地区国家的相关国家卫生统计信息库。这些数据集提供了有关卫生筹资指标、口腔健康覆盖率和口腔疾病负担的信息。描述性统计用于总结东南亚经合组织国家的指标。进行相关分析以检验卫生筹资指标与口腔健康结果和口腔健康覆盖率之间的相互关系。结果:政府卫生支出的增加与保险和口腔健康覆盖率呈显著正相关。它与自付费用(OOPE)、私人医疗支出、借钱支付医疗费用和“全因”DALYs(残疾调整生命年)呈负相关。政府卫生支出与“口腔疾病”DALYs之间没有显著相关性。私人支出的增加与国内一般政府保健支出占当前保健支出和口腔保健覆盖率的百分比呈负相关,与自付费用和为支付保健费用而借款呈正相关。政府支出的分配与口腔疾病的负担不成比例。讨论和结论:政府卫生资金与口腔疾病负担之间缺乏相关性,与口腔疾病负担占疾病总负担的份额相比,政府在口腔卫生方面的支出低得不成比例,这不仅表明资金严重不足,而且表明资金优先次序错位。有必要把重点放在预防口腔疾病上,并将资源直接用于卫生保健工作者和公众的预防、定期培训和教育,以确定口腔疾病的早期体征和症状,而不是仅仅用于治疗。
{"title":"Linking Health Financing to Oral Health Coverage and Disease Burden in SEARO Countries: A Cross-Sectional Analysis of Country Level Data","authors":"Shashidhar Acharya,&nbsp;Manu Raj Mathur,&nbsp;Santosh Kumar Tadakamadla,&nbsp;Angela Brand","doi":"10.1002/hpm.70027","DOIUrl":"10.1002/hpm.70027","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Introduction&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The Southeast Asian region of World Health Organization (SEARO) comprising 11 countries, that is Bangladesh, Bhutan, Democratic People's Republic of Korea, India, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand, and Timor-Leste is home to a quarter of the world's population where severe oral health disparities persist.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Aim&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This study aims to collate the oral health financing landscape, evaluate the relationship between government health expenditure and the burden of oral diseases, assess the proportionality of oral health spending relative to its share of the overall disease burden, and examine the inclusion and funding of dental care within Universal Health Coverage (UHC) benefit packages in the SEARO region.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Materials and Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Data for this study were sourced from publicly available databases and relevant national health statistics repositories of SEARO countries. These datasets provided information on health financing indicators, oral health coverage, and oral disease burden. Descriptive statistics were used to summarize indicators across SEARO countries. Correlation analyses were done to examine the interrelationship between health financing indicators and oral health outcomes and oral health coverage.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Increased government expenditure on health was significantly and positively correlated with insurance and oral health coverage. It was inversely correlated with out-of-pocket expenses (OOPE), private health expenditure, borrowing money to cover health expenses, and ‘All cause’ DALYs (Disability Adjusted Life Years). There was no significant correlation between government health spending and ‘Oral Disorders’ DALYs. Increased private expenditure was inversely correlated with domestic general government health expenditure as a percentage of current health expenditure and oral health coverage and positively correlated with Out-of-pocket expenses and borrowing money for covering health expenses. The allocation of government spending did not correspond proportionately to the burden of oral diseases.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Discussion and Conclusion&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The lack of correlation between government health funding and the oral disease burden and the disproportionately low government expenditure on oral health relative to the burden of oral diseases when compared to their sha","PeriodicalId":47637,"journal":{"name":"International Journal of Health Planning and Management","volume":"41 1","pages":"47-58"},"PeriodicalIF":1.8,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12794124/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145193227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Health Planning and Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1